Document Detail


Commentary: is totipotency of a human cell a sufficient reason to exclude its patentability under the European law?
MedLine Citation:
PMID:  17761756     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This article argues that totipotent character of human totipotent cells--defined as the capacity of a cell "to differentiate into all somatic lineages (ectoderm, mesoderm, endoderm), the germ line and extra-embryonic tissues such as the placenta"--is not a sufficient reason to exclude their patentability on the basis of Article 5(1) of the Directive 98/44/EC on the Legal Protection of Biotechnological Inventions (Biopatent Directive), which maintains that "the human body, at the various stages of its formation and development, [...] cannot constitute patentable inventions." Since human totipotent cells have both the potential to generate an entire new organism or to generate only different tissues or organs of an organism, they simultaneously fit the definition of the unpatentable human body at the earliest stage of its formation as well as of an element of the human body, which "may constitute a patentable invention" pursuant to Article 5(2) of the Biopatent Directive, whether that element is isolated from the human body or otherwise produced by means of a technical process. Therefore, this article suggests that, when evaluating patentability of human totipotent cells, they should be further evaluated according to their location and their method of derivation (i.e., whether human totipotent cells are located in the human body, whether they are isolated from the human body, or whether they are produced otherwise by means of a technical process). Disclosure of potential conflicts of interest is found at the end of this article.
Authors:
Katja Triller Vrtovec; Bojan Vrtovec
Related Documents :
3550806 - Castration reversibly alters levels of cholecystokinin immunoreactivity within cells of...
2456156 - 5-azacytidine accelerates yeast-mycelium conversion in candida albicans.
3019076 - Incipient germ cell tumor in sertoli-cell-only syndrome testis, accompanied with retrop...
12900446 - Gp130, the shared receptor for the lif/il6 cytokine family in the mouse, is not require...
1330656 - Characterization of a panel of rat ventral prostate epithelial cell lines immortalized ...
1675906 - Glial cells and neurons induce blood-brain barrier related enzymes in cultured cerebral...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2007-08-30
Journal Detail:
Title:  Stem cells (Dayton, Ohio)     Volume:  25     ISSN:  1549-4918     ISO Abbreviation:  Stem Cells     Publication Date:  2007 Dec 
Date Detail:
Created Date:  2007-12-17     Completed Date:  2008-03-26     Revised Date:  2008-08-06    
Medline Journal Info:
Nlm Unique ID:  9304532     Medline TA:  Stem Cells     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3026-8     Citation Subset:  IM    
Affiliation:
Max Planck Institute for Intellectual Property, Competition and Tax Law, München, Germany. katja.triller@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biotechnology / ethics,  legislation & jurisprudence
Cloning, Organism / ethics,  legislation & jurisprudence
Europe
Genetic Engineering / ethics,  legislation & jurisprudence
Humans
Patents as Topic / ethics,  legislation & jurisprudence*
Totipotent Stem Cells* / physiology
Comments/Corrections
Comment In:
Stem Cells. 2008 Jun;26(6):1656-7   [PMID:  18403750 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells.
Next Document:  Irradiation does not compromise or exacerbate the innate immune response in the brains of mice that ...